Nebido

DRUG3 trials

Sponsors

Sheffield Teaching Hospitals NHS Foundation Trust, Bayer, NU-Hospital Organization, Sweden

Conditions

Angina PectorisHypogonadismPuberty Delayed

Phase 4

Testosterone Therapy on Angina Threshold and Atheroma in Patients With Chronic Stable Angina

CompletedNCT00131183

Sheffield Teaching Hospitals NHS Foundation TrustAngina Pectoris

Start: 2005-09-30End: 2008-05-31Updated: 2019-10-02

Nebido Versus Placebo in Elderly Men With Typical Symptoms of Late Onset Hypogonadism Over a Period of 54 Weeks

WithdrawnNCT00710827

BayerHypogonadism

Start: 2008-10-31End: 2008-10-31Updated: 2012-11-27

Unknown Phase

Pubertal Replacement In Boys Study Nebido and Testoviron Depot Treatment

CompletedNCT05417035

NU-Hospital Organization, SwedenPuberty Delayed

Start: 2014-06-01End: 2020-08-01Updated: 2022-06-14

Related Papers

Pharmacological treatment for pubertal progression in boys with delayed or slow progression of puberty: A small-scale randomized study with testosterone enanthate and testosterone undecanoate treatment

Frontiers in Endocrinology2023-04-142 citations